• LAST PRICE
    0.7160
  • TODAY'S CHANGE (%)
    Trending Up0.0084 (1.1943%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.7047 / 0.7076
  • Day Range
    Low 0.7000
    High 0.7299
  • 52 Week Range
    Low 0.3862
    High 2.0500
  • Volume
    680,833
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.70755
TimeVolumeNWBO
09:32 ET168760.72
09:33 ET421640.72
09:35 ET127000.702
09:42 ET11590.71
09:46 ET308320.70505
09:48 ET175450.7001
09:50 ET55000.7122
09:51 ET60000.72
09:53 ET49950.7175
09:57 ET100000.7001
10:04 ET110010.7001
10:06 ET1250.7018
10:08 ET120000.7001
10:09 ET6250.7172
10:11 ET70980.708
10:13 ET511000.715
10:15 ET26850.7003
10:20 ET13850.7099
10:22 ET326500.7014
10:26 ET114000.7014
10:38 ET180000.7
10:49 ET115000.70425
10:51 ET10000.707
10:54 ET1800.707
10:56 ET2500.707
10:58 ET3000.707
11:02 ET31000.707
11:05 ET29300.70445
11:07 ET39000.704
11:12 ET50000.70445
11:14 ET8570.707
11:20 ET95000.70445
11:21 ET105000.7019
11:25 ET80380.7019
11:27 ET3000.70445
11:30 ET11000.70445
11:32 ET30000.707
11:34 ET14240.7055
11:39 ET54500.70695
11:43 ET7250.70695
11:52 ET5000.7099
11:56 ET15000.70995
11:57 ET20620.7125
12:10 ET1300.713
12:12 ET1100.713285
12:15 ET8700.71255
12:17 ET30000.71255
12:19 ET13160.7101
12:26 ET5280.7101
12:28 ET1000.715
12:32 ET102080.71255
12:33 ET25000.7101
12:37 ET9220.7126
12:39 ET84590.7126
12:42 ET15000.71284
12:44 ET112000.71255
12:46 ET40000.71255
12:50 ET100000.71255
12:53 ET18500.7101
12:55 ET1000.711
12:57 ET38000.711
01:04 ET60170.713
01:06 ET25000.713
01:13 ET15150.713
01:15 ET5500.713
01:20 ET20000.715
01:27 ET137780.7159
01:40 ET8000.7168
01:42 ET78000.71595
01:56 ET1350.7168
01:58 ET20000.7151
02:05 ET3040.71595
02:09 ET100000.7168
02:12 ET9820.71755
02:14 ET27560.71755
02:16 ET3000.71755
02:20 ET34940.72
02:21 ET20210.72
02:23 ET28480.724
02:25 ET103310.7255
02:27 ET4000.72025
02:30 ET110000.7205
02:32 ET13000.7151
02:39 ET67980.72
02:50 ET105000.7297
02:52 ET215000.7298
02:54 ET58000.7249
02:57 ET35000.7297
02:59 ET100000.7298
03:08 ET4000.729
03:10 ET110000.729
03:14 ET16000.7285
03:15 ET10000.72
03:19 ET58500.725
03:21 ET9500.72675
03:24 ET113000.72
03:26 ET54000.7225
03:28 ET75000.72
03:30 ET50000.7152
03:32 ET104100.7151
03:37 ET201500.7152
03:42 ET51000.7151
03:46 ET27770.7151
03:48 ET71230.7175
03:53 ET5000.7199
03:55 ET2860.7151
03:57 ET90000.7199
04:00 ET3360.716
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNWBO
Northwest Biotherapeutics Inc
744.9M
10.7x
---
United StatesDYN
Dyne Therapeutics Inc
736.6M
-4.0x
---
United StatesBLTE
Belite Bio Inc
756.7M
-87.0x
---
United StatesALT
Altimmune Inc
739.4M
-8.0x
---
United StatesCTIC
CTI Biopharma Corp
729.6M
-5.2x
---
United StatesCBAY
Cymabay Therapeutics Inc
722.3M
-6.9x
---
As of 2023-02-04

Company Information

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. Its wholly owned subsidiaries include Flaskworks, Aracaris Ltd, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.

Contact Information

Headquarters
SUITE 800, 4800 MONTGOMERY LANEBETHESDA, MD, United States 20814
Phone
240-497-9024
Fax
302-636-5454

Executives

Chairperson of the Board, President, Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer
Linda Powers
Senior Vice President, General Counsel
Leslie Goldman
Chief Technical Officer
Marnix Bosch
Chief Scientific Officer, Director
Alton Boynton
Lead Independent Director
Jerry Jasinowski

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$744.9M
Revenue (TTM)
$1.1M
Shares Outstanding
1.1B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.05
EPS
$0.07
Book Value
$-0.13
P/E Ratio
10.7x
Price/Sales (TTM)
686.0
Price/Cash Flow (TTM)
12.9x
Operating Margin
-5,511.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.